Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
23.22
-1.08 (-4.44%)
At close: Nov 20, 2026, 4:00 PM EST
23.17
-0.05 (-0.22%)
After-hours: Nov 20, 2026, 7:30 PM EST
Damora Therapeutics Employees
Damora Therapeutics had 7 employees as of December 31, 2025. The number of employees increased by 2 or 40.00% compared to the previous year. That makes Damora Therapeutics the 40,977th largest employer in the world and 6,223rd in the United States.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$37,552,286
Market Cap
1.44B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | 2 | 40.00% |
| Dec 31, 2024 | 5 | -8 | -61.54% |
| Dec 31, 2023 | 13 | -32 | -71.11% |
| Dec 31, 2022 | 45 | 5 | 12.50% |
| Dec 31, 2021 | 40 | 12 | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Nurix Therapeutics | 317 |
| Mesoblast | 108 |
| AnaptysBio | 104 |
| Tyra Biosciences | 87 |
| Rapport Therapeutics | 84 |
DMRA News
- 3 days ago - Damora Therapeutics Transcript: Jefferies Global Healthcare Conference - Transcripts
- 5 days ago - Damora Therapeutics Transcript: UBS Global Biopharma Conference 2026 - Transcripts
- 12 days ago - Damora Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 16 days ago - Damora Therapeutics price target lowered to $59 from $60 at Guggenheim - TheFly
- 17 days ago - Damora Therapeutics reports Q3 EPS (40c), consensus (44c) - TheFly
- 17 days ago - Damora Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 17 days ago - Damora Therapeutics to Present New Preclinical Data Highlighting Potentially Best-in-Class Pan-Mutant Activity of DMR-001 in Mutant Calreticulin (mutCALR)-driven Myeloproliferative Neoplasms (MPN) at the American Society of Hematology (ASH) 2026 Annual Meeting - GlobeNewsWire
- 18 days ago - Damora Therapeutics Quarterly report: Q3 2026 - Filings